Active substance
Clemastine
- SFDA 3
- US FDA 15
- US price lines 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| TAVEGYL INJ 2MG-2ML | 1 mg/ml | Injection · Intravenous use | 5 Ampoule | SAR 15.30 | NCE · Prescription | NOVARTIS | Withdrawn by MAH · Not Marketed |
| TAVEGYL SYRUP 1MG-10 CC | 0.1 mg/ml | Syrup · Oral use | 1 Bottle | SAR 19.40 | NCE · Prescription | NOVARTIS | Withdrawn by MAH · Not Marketed |
| TAVEGYL TAB 1MG | 1 mg | Tablet · Oral use | 20 Blister | SAR 16.15 | NCE · Prescription | NOVARTIS | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CLEMASTINE FUMARATE | 2.68MG | tablet · oral | GENUS | Prescription | 31 Jan 1992 |
| CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | syrup · oral | GENUS | Prescription | 30 Jun 1994 |
| CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | syrup · oral | GENUS LIFESCIENCES | Prescription | 17 Dec 1997 |
| TAVIST | 2.68MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | NOVARTIS | Discontinued | 25 Feb 1977 |
| TAVIST-1 | 1.34MG | tablet · oral | NOVARTIS | Discontinued | 25 Feb 1977 |
| TAVIST | EQ 0.5MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | syrup · oral | NOVARTIS | Discontinued | 28 Jun 1985 |
| CLEMASTINE FUMARATE | 1.34MG | tablet · oral | ANI PHARMS | Discontinued | 31 Jan 1992 |
| CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | syrup · oral | TEVA PHARMS | Discontinued | 21 Apr 1992 |
| TAVIST-1 | 1.34MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | HALEON US HOLDINGS | Discontinued | 21 Aug 1992 |
| CLEMASTINE FUMARATE | 1.34MG | tablet · oral | PLD ACQUISITIONS LLC | Discontinued | 31 Oct 1993 |
| CLEMASTINE FUMARATE | 2.68MG | tablet · oral | OMNIVIUM PHARMS | Discontinued | 31 Oct 1993 |
| CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | syrup · oral | ACTAVIS MID ATLANTIC | Discontinued | 31 Oct 1993 |
| CLEMASTINE FUMARATE | 1.34MG | tablet · oral | L PERRIGO CO | Discontinued | 22 Nov 1995 |
| CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | syrup · oral | WOCKHARDT BIO AG | Discontinued | 13 Mar 1998 |
| CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | syrup · oral | APOTEX INC | Discontinued | 27 Nov 2000 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | CLEMASTINE 0.5 MG/5 ML SYRUP | $5.49167 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.